Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1788170
Max Phase: Preclinical
Molecular Formula: C27H28N4O7S
Molecular Weight: 436.54
Molecule Type: Small molecule
Associated Items:
ID: ALA1788170
Max Phase: Preclinical
Molecular Formula: C27H28N4O7S
Molecular Weight: 436.54
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CN(Cc1ccc(S(=O)(=O)N2CCNCC2)cc1)c1ccc2c3c(cccc13)C(=O)N2.O=C(O)/C=C\C(=O)O
Standard InChI: InChI=1S/C23H24N4O3S.C4H4O4/c1-26(21-10-9-20-22-18(21)3-2-4-19(22)23(28)25-20)15-16-5-7-17(8-6-16)31(29,30)27-13-11-24-12-14-27;5-3(6)1-2-4(7)8/h2-10,24H,11-15H2,1H3,(H,25,28);1-2H,(H,5,6)(H,7,8)/b;2-1-
Standard InChI Key: VDSWBMPOOFDNNK-BTJKTKAUSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 436.54 | Molecular Weight (Monoisotopic): 436.1569 | AlogP: 2.64 | #Rotatable Bonds: 5 |
Polar Surface Area: 81.75 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 7.16 | CX LogP: 2.43 | CX LogD: 2.23 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.64 | Np Likeness Score: -1.38 |
1. Varney MD, Marzoni GP, Palmer CL, Deal JG, Webber S, Welsh KM, Bacquet RJ, Bartlett CA, Morse CA, Booth CL.. (1992) Crystal-structure-based design and synthesis of benz[cd]indole-containing inhibitors of thymidylate synthase., 35 (4): [PMID:1542093] [10.1021/jm00082a006] |
Source(1):